vs
Ascendis Pharma A/S（ASND）与Forestar Group Inc.（FOR）财务数据对比。点击上方公司名可切换其他公司
Forestar Group Inc.的季度营收约是Ascendis Pharma A/S的1.0倍（$273.0M vs $267.3M），Ascendis Pharma A/S同比增速更快（42.3% vs 9.0%），过去两年Ascendis Pharma A/S的营收复合增速更高（60.7% vs -9.6%）
Ascendis Pharma A/S是一家聚焦内分泌疾病治疗领域的生物制药企业，核心业务覆盖生长激素疗法的研发、生产与商业化。其依托重组DNA技术生产的生长激素类处方药物，可用于治疗多种生长激素缺乏相关适应症，临床应用场景广泛。
福雷斯特集团是一家住宅地块开发企业，总部位于得克萨斯州阿灵顿，业务覆盖美国21个州的51个市场。截至2020年12月31日的12个月内，该公司交付了11518块住宅地块，目前在纽约证券交易所上市，自2002年起就是美国规模最大的住宅建筑商D.R. Horton的控股子公司。
ASND vs FOR — 直观对比
营收规模更大
FOR
是对方的1.0倍
$267.3M
营收增速更快
ASND
高出33.3%
9.0%
两年增速更快
ASND
近两年复合增速
-9.6%
损益表 — Q4 FY2025 vs Q1 FY2026
| 指标 | | |
|---|---|---|
| 营收 | $267.3M | $273.0M |
| 净利润 | — | $15.4M |
| 毛利率 | 90.5% | 20.1% |
| 营业利润率 | — | 7.6% |
| 净利率 | — | 5.6% |
| 营收同比 | 42.3% | 9.0% |
| 净利润同比 | — | -6.7% |
| 每股收益（稀释后） | — | $0.30 |
绿色 = 该指标领先。财年不对齐时期间可能不同
8季度营收与利润趋势
并排季度历史对比，按日历期对齐，财年错位的公司也能正确匹配
营收ASNDFOR
| Q4 25 | $267.3M | $273.0M | ||
| Q3 25 | $230.7M | $670.5M | ||
| Q2 25 | $170.7M | $390.5M | ||
| Q1 25 | $109.0M | $351.0M | ||
| Q4 24 | $187.8M | $250.4M | ||
| Q3 24 | $62.5M | $551.3M | ||
| Q2 24 | $38.9M | $318.4M | ||
| Q1 24 | $103.6M | $333.8M |
净利润ASNDFOR
| Q4 25 | — | $15.4M | ||
| Q3 25 | $-65.9M | $86.9M | ||
| Q2 25 | $-42.0M | $32.9M | ||
| Q1 25 | $-102.2M | $31.6M | ||
| Q4 24 | — | $16.5M | ||
| Q3 24 | $-107.1M | $81.5M | ||
| Q2 24 | $-118.1M | $38.7M | ||
| Q1 24 | $-141.5M | $45.0M |
毛利率ASNDFOR
| Q4 25 | 90.5% | 20.1% | ||
| Q3 25 | 89.5% | 22.3% | ||
| Q2 25 | 80.1% | 20.4% | ||
| Q1 25 | 82.6% | 22.6% | ||
| Q4 24 | 91.9% | 22.0% | ||
| Q3 24 | 80.6% | 23.9% | ||
| Q2 24 | 68.2% | 22.5% | ||
| Q1 24 | 92.1% | 24.9% |
营业利润率ASNDFOR
| Q4 25 | — | 7.6% | ||
| Q3 25 | 5.1% | 16.9% | ||
| Q2 25 | -33.5% | 11.2% | ||
| Q1 25 | -103.2% | 11.6% | ||
| Q4 24 | — | 8.7% | ||
| Q3 24 | -167.3% | 19.7% | ||
| Q2 24 | -370.2% | 16.2% | ||
| Q1 24 | -51.2% | 17.6% |
净利率ASNDFOR
| Q4 25 | — | 5.6% | ||
| Q3 25 | -28.5% | 13.0% | ||
| Q2 25 | -24.6% | 8.4% | ||
| Q1 25 | -93.7% | 9.0% | ||
| Q4 24 | — | 6.6% | ||
| Q3 24 | -171.5% | 14.8% | ||
| Q2 24 | -303.9% | 12.2% | ||
| Q1 24 | -136.6% | 13.5% |
每股收益（稀释后）ASNDFOR
| Q4 25 | — | $0.30 | ||
| Q3 25 | — | $1.70 | ||
| Q2 25 | — | $0.65 | ||
| Q1 25 | — | $0.62 | ||
| Q4 24 | — | $0.32 | ||
| Q3 24 | — | $1.59 | ||
| Q2 24 | — | $0.76 | ||
| Q1 24 | — | $0.89 |
资产负债表与财务实力
最新季度各公司的流动性、杠杆与账面价值一览
| 指标 | | |
|---|---|---|
| 现金及短期投资手头流动性 | $665.3M | $211.7M |
| 总债务越低越好 | — | $793.2M |
| 股东权益账面价值 | $-175.8M | $1.8B |
| 总资产 | $1.4B | $3.2B |
| 负债/权益比越低杠杆越低 | — | 0.44× |
8季度趋势，按日历期对齐
现金及短期投资ASNDFOR
| Q4 25 | $665.3M | $211.7M | ||
| Q3 25 | $582.2M | $379.2M | ||
| Q2 25 | $533.6M | $189.2M | ||
| Q1 25 | $559.4M | $174.3M | ||
| Q4 24 | $604.3M | $132.0M | ||
| Q3 24 | $675.6M | $481.2M | ||
| Q2 24 | $279.4M | $359.2M | ||
| Q1 24 | $345.9M | $416.2M |
总债务ASNDFOR
| Q4 25 | — | $793.2M | ||
| Q3 25 | — | $802.7M | ||
| Q2 25 | — | $872.8M | ||
| Q1 25 | — | $872.5M | ||
| Q4 24 | — | $806.8M | ||
| Q3 24 | — | $706.4M | ||
| Q2 24 | — | $706.1M | ||
| Q1 24 | — | $705.7M |
股东权益ASNDFOR
| Q4 25 | $-175.8M | $1.8B | ||
| Q3 25 | $-188.0M | $1.8B | ||
| Q2 25 | $-202.6M | $1.7B | ||
| Q1 25 | $-205.0M | $1.6B | ||
| Q4 24 | $-114.2M | $1.6B | ||
| Q3 24 | $-105.1M | $1.6B | ||
| Q2 24 | $-346.8M | $1.5B | ||
| Q1 24 | $-257.2M | $1.5B |
总资产ASNDFOR
| Q4 25 | $1.4B | $3.2B | ||
| Q3 25 | $1.2B | $3.1B | ||
| Q2 25 | $1.2B | $3.1B | ||
| Q1 25 | $1.1B | $3.0B | ||
| Q4 24 | $1.3B | $3.0B | ||
| Q3 24 | $1.2B | $2.8B | ||
| Q2 24 | $819.0M | $2.7B | ||
| Q1 24 | $866.7M | $2.6B |
负债/权益比ASNDFOR
| Q4 25 | — | 0.44× | ||
| Q3 25 | — | 0.45× | ||
| Q2 25 | — | 0.52× | ||
| Q1 25 | — | 0.53× | ||
| Q4 24 | — | 0.50× | ||
| Q3 24 | — | 0.44× | ||
| Q2 24 | — | 0.47× | ||
| Q1 24 | — | 0.48× |
现金流与资本效率
扣除再投资后实际产生的现金。现金流比净利润更难造假
| 指标 | | |
|---|---|---|
| 经营现金流最新季度 | $58.2M | $-157.0M |
| 自由现金流经营现金流 - 资本支出 | — | $-157.1M |
| 自由现金流率自由现金流/营收 | — | -57.5% |
| 资本支出强度资本支出/营收 | — | 0.0% |
| 现金转化率经营现金流/净利润 | — | -10.19× |
| 过去12个月自由现金流最近4个季度 | — | $93.0M |
8季度趋势，按日历期对齐
经营现金流ASNDFOR
| Q4 25 | $58.2M | $-157.0M | ||
| Q3 25 | — | $256.3M | ||
| Q2 25 | — | $15.8M | ||
| Q1 25 | $-15.5M | $-19.8M | ||
| Q4 24 | $-330.7M | $-450.0M | ||
| Q3 24 | — | $119.2M | ||
| Q2 24 | — | $-61.7M | ||
| Q1 24 | $-109.7M | $-59.2M |
自由现金流ASNDFOR
| Q4 25 | — | $-157.1M | ||
| Q3 25 | — | $255.6M | ||
| Q2 25 | — | $15.0M | ||
| Q1 25 | — | $-20.5M | ||
| Q4 24 | — | — | ||
| Q3 24 | — | $118.4M | ||
| Q2 24 | — | $-62.3M | ||
| Q1 24 | — | $-59.8M |
自由现金流率ASNDFOR
| Q4 25 | — | -57.5% | ||
| Q3 25 | — | 38.1% | ||
| Q2 25 | — | 3.8% | ||
| Q1 25 | — | -5.8% | ||
| Q4 24 | — | — | ||
| Q3 24 | — | 21.5% | ||
| Q2 24 | — | -19.6% | ||
| Q1 24 | — | -17.9% |
资本支出强度ASNDFOR
| Q4 25 | — | 0.0% | ||
| Q3 25 | — | 0.1% | ||
| Q2 25 | — | 0.2% | ||
| Q1 25 | — | 0.2% | ||
| Q4 24 | — | 0.0% | ||
| Q3 24 | — | 0.1% | ||
| Q2 24 | — | 0.2% | ||
| Q1 24 | — | 0.2% |
现金转化率ASNDFOR
| Q4 25 | — | -10.19× | ||
| Q3 25 | — | 2.95× | ||
| Q2 25 | — | 0.48× | ||
| Q1 25 | — | -0.63× | ||
| Q4 24 | — | -27.27× | ||
| Q3 24 | — | 1.46× | ||
| Q2 24 | — | -1.59× | ||
| Q1 24 | — | -1.32× |
财务流量对比
营收 → 毛利润 → 营业利润 → 净利润流向图
业务分部营收拆解
ASND
暂无分部数据
FOR
| D.R.Horton Inc. | $183.8M | 67% |
| Other | $89.2M | 33% |
